over 6 1/2 years , 182 patients with acute myelogenous leukaemia were treated with one of two combinations of chemotherapy containing cytosine arabinoside and an anthracycline ( daunorubicin or doxorubicin ) .
C0011015
daunorubicin
C0013089
doxorubicin